Certain Ordinary Shares of CytoMed Therapeutics Limited are subject to a Lock-Up Agreement Ending on 14-APR-2024. These Ordinary Shares will be under lockup for 367 days starting from 13-APR-2023 to 14-APR-2024.

Details:
Members of Board, and executive officers and shareholders beneficially owning more than 5% of outstanding ordinary shares as of the effective date of this Prospectus has agreed during the 12-month period following the date of this Prospectus to substantially similar lock-up provisions, subject to certain exceptions.